| Literature DB >> 30004821 |
Francisco Schlottmann1, Martin M Galvarini1, Nicolás H Dreifuss1, Francisco Laxague1, Rudolf Buxhoeveden1, Verónica Gorodner2.
Abstract
The number of obese people in the world has risen significantly over the past three decades. Obesity is associated with severe health comorbidities and metabolic disorders such as diabetes, hypertension, dyslipidemia, and nonalcoholic fatty liver disease. Even with aggressive pharmacotherapy, obese patients will have substantial poor health outcomes. Bariatric surgery has been used more often during the last 10 years as it has been shown to be safe and effective in decreasing weight. The term "metabolic surgery" has recently emerged from the recognition that the effects of surgery on comorbidities extended beyond weight loss. Most patients suffering from metabolic disorders will obtain significant improvements after surgery.Entities:
Keywords: bariatric surgery; diabetes; hypertension; obesity
Mesh:
Year: 2018 PMID: 30004821 DOI: 10.1089/lap.2018.0394
Source DB: PubMed Journal: J Laparoendosc Adv Surg Tech A ISSN: 1092-6429 Impact factor: 1.878